| LncRNA Information | ||||||
|---|---|---|---|---|---|---|
| ID | EL1228 | Name | SNHG3 | Aliases | NCRNA00014; RNU17C; RNU17D; U17HG; U17HG-A; U17HG-AB | |
| Species | Homo sapiens | Chromosome | 1 | Start site | 28505980 | |
| End site | 28510892 | Chain | plus | Exon NO. | 4 | |
| Assembly | Ensembl Release 89 | Class | retained intron | NCBI accession | NR_036473, NR_002909 | |
| Ensembl | ENSG00000242125 | Sequence | ||||
| Disease | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
| Alzheimer's disease | N/A | N/A | N/A | expression | We selected three differential signature genes specific for the early stage (Nudt19, Arl16, Aph1b), five common to both groups (Slc15a2, Agpat5, Sox2ot, 2210015, D19Rik, Wdfy1), and seven specific for late stage. | 21961160 | LncRNADisease | ||
| hepatocelluar carcinoma | RNA-seq, qPCR, ISH etc. | HCC tissue | up-regulated | expression | Our results showed that the expression level of SNHG3 was significantly upregulated in HCC tissues compared with paired noncancerous tissues from 51 HCC patients, increased SNHG3 expression is associated with malignant status and poor prognosis in HCC patients. | 26373735 | Lnc2Cancer | ||